• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB1800188 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-09-10 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-02-02 view
JYSB2200095 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-06-09 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB2300183 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-10-26 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB1800047 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-03-26 Bayer Healthcare LLC Certificate Issued 2018-07-27 view
JYSB2101028 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-05-12 Bayer Healthcare LLC view
JYSZ2200027 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2022-06-29 Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd view
JYSZ1600012 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2016-05-10 Baxter AG;Baxalta Manufacturing Sàrl Certificate Issued 2017-04-19 view
JYSB2500202 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-09-05 Bayer Healthcare LLC view
JYSB1900244 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-09-05 Wyeth Farma SA;Pfizer Ltd Filed 2019-09-16 view
JYSB2200065 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-04-08 Novo Nordisk A/S view
JYSB1500125 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2015-05-08 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2015-08-12 view
CXSL2200294 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(2.4) New Drug Application 2022-06-28 Zhuangya (Beijing) Biotechnology Co Ltd view
JYSB2400251 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-12-04 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB1000025 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2010-02-09 Bayer Healthcare LLC Certificate Issued 2010-12-27 view
JYSB2000559 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-11-04 Bayer Healthcare LLC Filed 2020-11-17 view
JYSB2200144 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-08-08 Bayer Healthcare LLC view
CXSL2400210 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2024-04-03 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JYSB1800114 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-05-17 Baxter AG;Baxalta Manufacturing Sàrl Filed 2018-05-30 view
JYSB2000430 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-09-03 Pfizer Europe Ma Eeig;Wyeth Farma SA Certificate Issued 2020-10-27 view
JXSS2200007 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.1) Import Drug Application 2022-01-26 Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd view